Search results
Author(s):
Natnicha Pongbangli
,
Thanaporn Anuchai
,
Sasivimon Jai-aue
,
et al
Added:
3 days ago
Author(s):
Kapil Rajendran
,
Abdul Salam
,
Jayaram Vasu
Added:
1 year ago
Author(s):
Heng Shee Kim
,
Hou Tee Lu
Added:
1 year ago
Author(s):
Billy Joseph David
,
Reynald Evan R Tugade
,
Ferdinand Jr Gerodias
Added:
2 years ago
Author(s):
Colin Yeo
,
Xuan Han Koh
,
Weien Chow
,
et al
Added:
9 months ago
Author(s):
Jonas Brinck
Added:
4 months ago
ESC Congress 2025 - Cascade screening proves to be an effective tool to identify more patients with elevated LP(a) levels.Dr Jonas Brinck (Karolinska Institute, SE) joins us to discuss findings from the LipoaScreen study, evaluating cascade screening for elevated lipoprotein(a) in relatives of patients with atherosclerotic coronary artery disease.This prospective study examined whether elevated…
View more
Author(s):
Michelle O'Donoghue
Added:
2 years ago
ESC 23 — Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) outlines a trial update from OCEAN(a)-Dose Extension trial (NCT05581303) in this succinct interview.
OCEAN(a)-DOSE (Amgen) was a dose-finding study aiming to evaluate a siRNA, olpasiran, and its effect on risk for coronary heart disease death, myocardial infarction or urgent coronary revascularization when administered…
View more
Author(s):
Nirmalatiban Parthiban
,
Fiona Boland
,
Huzairi Sani
Added:
9 months ago
Added:
3 months ago
Source:
Transcatheter Academy
The long-term durability of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease has been a subject of recent debate. New 3-year follow-up data from the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) trial show that the clinical benefits of a physiology-guided complete revascularization strategy are sustained over time…
View more